Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.29 trillion and total revenue of $122.01 billion.
Market Cap
1.29T
Revenue
122.01B
Profits
-33.49B
PE Ratio
n/a
Profit Margin
-27.44%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 138.02B | -0.85% | 1,513,248 | 12.95B |
| 2 | MRNA | Moderna, Inc. | 96.05B | -6.89% | 8,901,650 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 91.18B | -2.37% | 906,993 | 16.90B |
| 4 | ARGX | argenx SE | 55.72B | -2.65% | 285,321 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 44.55B | 3.71% | 728,814 | 6.61B |
| 6 | RPRX | Royalty Pharma plc | 39.00B | 0.64% | 3,388,649 | 2.62B |
| 7 | RVMD | Revolution Medicines, Inc. | 38.99B | -8.91% | 5,655,181 | 197.56M |
| 8 | GMAB | Genmab A/S | 31.11B | -3.10% | 3,089,420 | 4.13B |
| 9 | ROIV | Roivant Sciences Ltd. | 26.59B | -3.71% | 6,012,459 | 7.53M |
| 10 | INCY | Incyte Corporation | 24.24B | -3.22% | 744,256 | 6.01B |
| 11 | INSM | Insmed Incorporated | 23.56B | -2.37% | 1,409,596 | 1.52B |
| 12 | BNTX | BioNTech SE | 21.51B | -4.34% | 594,498 | 2.75B |
| 13 | ALNY | Alnylam Pharmaceuticals, Inc. | 21.40B | -0.80% | 2,026,938 | 5.01B |
| 14 | EXEL | Exelixis, Inc. | 17.04B | -4.03% | 2,144,374 | 2.50B |
| 15 | ASND | Ascendis Pharma A/S | 16.68B | -1.54% | 301,007 | 1.20B |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 14.70B | -2.40% | 423,290 | 4.72B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 14.55B | -4.11% | 2,389,542 | 945.54M |
| 18 | HALO | Halozyme Therapeutics, Inc. | 14.26B | -3.61% | 1,577,711 | 1.66B |
| 19 | SMMT | Summit Therapeutics Inc. | 11.52B | -10.95% | 3,894,131 | - |
| 20 | TECH | Bio-Techne Corporation | 11.40B | -0.03% | 3,522,280 | 1.22B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.96B | -1.00% | 1,006,405 | 3.66B |
| 22 | KYMR | Kymera Therapeutics, Inc. | 10.82B | -6.95% | 911,039 | 102.24M |
| 23 | PCVX | Vaxcyte, Inc. | 9.94B | -3.81% | 782,963 | - |
| 24 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.42B | 1.23% | 585,536 | 1.43B |
| 25 | SYRE | Spyre Therapeutics, Inc. | 9.21B | -2.11% | 604,726 | - |
| 26 | KRYS | Krystal Biotech, Inc. | 9.00B | -2.33% | 150,226 | 470.03M |
| 27 | PTGX | Protagonist Therapeutics, Inc. | 8.91B | -4.00% | 261,727 | 281.99M |
| 28 | IBRX | ImmunityBio, Inc. | 8.65B | -8.62% | 9,544,268 | 165.79M |
| 29 | TGTX | TG Therapeutics, Inc. | 8.34B | -4.61% | 1,191,550 | 799.54M |
| 30 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.13B | -6.68% | 1,157,563 | 669.50M |
| 31 | CORT | Corcept Therapeutics Incorporated | 7.99B | -7.81% | 827,250 | 963.65M |
| 32 | CYTK | Cytokinetics, Incorporated | 7.69B | -12.99% | 4,755,020 | 113.29M |
| 33 | TWST | Twist Bioscience Corporation | 7.64B | -14.52% | 2,249,683 | 431.80M |
| 34 | ABVX | ABIVAX Société Anonyme | 7.46B | -4.19% | 955,857 | 5.33M |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 7.39B | -7.03% | 172,906 | 7.46M |
| 36 | CAI | Caris Life Sciences, Inc. | 7.33B | -21.88% | 6,149,218 | 1.05B |
| 37 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.23B | -5.76% | 4,114,541 | 280.75M |
| 38 | AXSM | Axsome Therapeutics, Inc. | 6.93B | -3.80% | 710,934 | 865.27M |
| 39 | IONS | Ionis Pharmaceuticals, Inc. | 6.41B | -3.91% | 1,206,553 | 874.09M |
| 40 | ORKA | Oruka Therapeutics, Inc. | 6.41B | -4.57% | 435,178 | - |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 6.13B | -3.10% | 542,358 | 670.78M |
| 42 | LGND | Ligand Pharmaceuticals Incorporated | 6.08B | -3.82% | 137,509 | 253.83M |
| 43 | IMVT | Immunovant, Inc. | 5.92B | -4.18% | 480,609 | - |
| 44 | KOD | Kodiak Sciences Inc. | 5.85B | -5.26% | 679,743 | - |
| 45 | CGON | CG Oncology, Inc. | 5.82B | -3.09% | 479,072 | 6.23M |
| 46 | BLTE | Belite Bio, Inc | 5.81B | -6.38% | 178,763 | - |
| 47 | PTCT | PTC Therapeutics, Inc. | 5.58B | -3.10% | 650,877 | 1.16B |
| 48 | SRRK | Scholar Rock Holding Corporation | 5.51B | -1.78% | 916,970 | - |
| 49 | MANE | Veradermics, Incorporated | 5.38B | -5.63% | 495,012 | - |
| 50 | COGT | Cogent Biosciences, Inc. | 5.15B | -5.84% | 1,658,007 | - |
| 51 | ERAS | Erasca, Inc. | 4.78B | -8.38% | 4,333,372 | - |
| 52 | CRSP | CRISPR Therapeutics AG | 4.73B | -5.80% | 1,303,782 | 25.17M |
| 53 | TVTX | Travere Therapeutics, Inc. | 4.71B | -6.35% | 977,339 | 651.03M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.70B | -2.11% | 634,199 | 2.72M |
| 55 | LEGN | Legend Biotech Corporation | 4.37B | -1.01% | 2,198,559 | 1.27B |
| 56 | EWTX | Edgewise Therapeutics, Inc. | 4.30B | 5.38% | 3,544,241 | - |
| 57 | DFTX | Definium Therapeutics, Inc. | 4.17B | -4.98% | 1,230,043 | - |
| 58 | RLAY | Relay Therapeutics, Inc. | 3.74B | -5.38% | 2,370,755 | 10.35M |
| 59 | ACAD | Acadia Pharmaceuticals Inc. | 3.69B | -0.28% | 4,681,041 | 1.20B |
| 60 | XENE | Xenon Pharmaceuticals Inc. | 3.68B | -3.04% | 642,958 | 7.50M |
| 61 | TNGX | Tango Therapeutics, Inc. | 3.67B | -6.13% | 2,137,108 | 53.81M |
| 62 | ABCL | AbCellera Biologics Inc. | 3.67B | -7.82% | 3,128,948 | 66.17M |
| 63 | IOVA | Iovance Biotherapeutics, Inc. | 3.57B | -9.31% | 17,817,929 | 378.98M |
| 64 | IRON | Disc Medicine, Inc. | 3.54B | -4.38% | 395,779 | - |
| 65 | PBLS | Parabilis Medicines, Inc. | 3.46B | -7.67% | 479,142 | 148.00K |
| 66 | ARQT | Arcutis Biotherapeutics, Inc. | 3.44B | -20.12% | 5,267,631 | 508.68M |
| 67 | TARS | Tarsus Pharmaceuticals, Inc. | 3.35B | -1.68% | 575,988 | 682.20M |
| 68 | ELVN | Enliven Therapeutics, Inc. | 3.31B | -4.32% | 886,717 | - |
| 69 | DYN | Dyne Therapeutics, Inc. | 3.29B | -4.91% | 1,759,952 | - |
| 70 | VKTX | Viking Therapeutics, Inc. | 3.29B | -7.76% | 3,317,760 | - |
| 71 | VRDN | Viridian Therapeutics, Inc. | 3.28B | -0.36% | 2,423,683 | 26.31M |
| 72 | TLX | Telix Pharmaceuticals Limited | 3.27B | -2.38% | 190,824 | 890.79M |
| 73 | DNLI | Denali Therapeutics Inc. | 3.21B | -4.53% | 1,369,163 | 21.38M |
| 74 | CELC | Celcuity Inc. | 3.17B | -6.51% | 704,416 | - |
| 75 | IDYA | IDEAYA Biosciences, Inc. | 2.99B | -4.57% | 648,662 | 36.54M |
| 76 | ADMA | ADMA Biologics, Inc. | 2.93B | 25.95% | 12,155,893 | 519.15M |
| 77 | ZLAB | Zai Lab Limited | 2.80B | -0.92% | 430,014 | 441.73M |
| 78 | VCEL | Vericel Corporation | 2.64B | 13.54% | 1,812,883 | 324.17M |
| 79 | XNCR | Xencor, Inc. | 2.62B | -0.29% | 808,090 | 200.49M |
| 80 | RCUS | Arcus Biosciences, Inc. | 2.60B | -6.27% | 1,125,202 | 100.00M |
| 81 | BEAM | Beam Therapeutics Inc. | 2.58B | -6.69% | 2,203,475 | 146.64M |
| 82 | MBX | MBX Biosciences, Inc. | 2.35B | -7.16% | 237,709 | - |
| 83 | PHVS | Pharvaris N.V. | 2.34B | -2.85% | 627,755 | - |
| 84 | NAMS | NewAmsterdam Pharma Company N.V. | 2.32B | -7.07% | 895,076 | 25.94M |
| 85 | PVLA | Palvella Therapeutics, Inc. | 2.26B | -3.17% | 188,104 | - |
| 86 | CLDX | Celldex Therapeutics, Inc. | 2.24B | -4.84% | 524,473 | 158.00K |
| 87 | SEPN | Septerna, Inc. | 2.23B | -0.17% | 327,928 | 98.88M |
| 88 | VERA | Vera Therapeutics, Inc. | 2.22B | -3.85% | 855,929 | - |
| 89 | RXRX | Recursion Pharmaceuticals, Inc. | 2.18B | -9.66% | 19,417,255 | 68.23M |
| 90 | AUPH | Aurinia Pharmaceuticals Inc. | 2.18B | -4.73% | 617,531 | 321.74M |
| 91 | BHVN | Biohaven Ltd. | 2.14B | -6.96% | 2,123,016 | - |
| 92 | IMNM | Immunome, Inc. | 2.13B | -7.68% | 1,540,257 | 4.02M |
| 93 | LKFT | Lakefront Biotherapeutics NV | 2.12B | -0.97% | 222,241 | 1.13B |
| 94 | COAG | Hemab Therapeutics Holdings, Inc. | 2.11B | - | 254,214 | - |
| 95 | ZYME | Zymeworks Inc. | 2.09B | -4.72% | 822,379 | 37.13M |
| 96 | FTRE | Fortrea Holdings Inc. | 1.98B | -1.39% | 1,595,126 | 2.67B |
| 97 | MESO | Mesoblast Limited | 1.95B | -0.98% | 174,616 | 120.25M |
| 98 | TRAX | First Tracks Biotherapeutics, Inc. | 1.94B | -6.08% | 363,581 | - |
| 99 | REPL | Replimune Group, Inc. | 1.91B | -2.56% | 2,608,121 | - |
| 100 | HRMY | Harmony Biosciences Holdings, Inc. | 1.91B | -4.84% | 887,094 | 989.36M |
| 101 | VIR | Vir Biotechnology, Inc. | 1.91B | -4.25% | 2,067,888 | 302.80M |
| 102 | SRPT | Sarepta Therapeutics, Inc. | 1.89B | -6.00% | 826,204 | 1.97B |
| 103 | TRVI | Trevi Therapeutics, Inc. | 1.87B | -6.26% | 687,352 | - |
| 104 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.84B | -8.42% | 2,011,738 | 213.00M |
| 105 | ZBIO | Zenas BioPharma, Inc. | 1.77B | -4.46% | 454,347 | 11.00M |
| 106 | MAZE | Maze Therapeutics, Inc. | 1.75B | -2.52% | 291,064 | 20.00M |
| 107 | STOK | Stoke Therapeutics, Inc. | 1.72B | -4.30% | 638,422 | 28.21M |
| 108 | AGIO | Agios Pharmaceuticals, Inc. | 1.69B | -9.53% | 1,482,331 | 140.84M |
| 109 | NRIX | Nurix Therapeutics, Inc. | 1.67B | -3.98% | 4,315,069 | 701.94M |
| 110 | LYCA | Lycia Therapeutics, Inc. | 1.66B | -0.24% | 97,545 | 4.44M |
| 111 | ABSI | Absci Corporation | 1.64B | -8.59% | 3,558,778 | 1.56M |
| 112 | GENB | Generate Biomedicines, Inc. | 1.63B | -10.38% | 646,498 | 26.48M |
| 113 | NVAX | Novavax, Inc. | 1.61B | -8.26% | 6,213,082 | 413.80M |
| 114 | SLS | SELLAS Life Sciences Group, Inc. | 1.61B | -12.86% | 8,621,315 | - |
| 115 | KLRA | Kailera Therapeutics, Inc. | 1.58B | -4.69% | 430,044 | - |
| 116 | NBTX | Nanobiotix S.A. | 1.58B | 1.31% | 488,340 | 13.15M |
| 117 | NTLA | Intellia Therapeutics, Inc. | 1.57B | -9.18% | 5,406,674 | 52.89M |
| 118 | ADRX | ADARx Pharmaceuticals, Inc. | 1.56B | -6.89% | 545,479 | 6.13M |
| 119 | RARE | Ultragenyx Pharmaceutical Inc. | 1.55B | -7.81% | 3,843,870 | 730.00M |
| 120 | NUVB | Nuvation Bio Inc. | 1.53B | -7.72% | 5,875,757 | 201.73M |
| 121 | TYRA | Tyra Biosciences, Inc. | 1.47B | -0.77% | 302,201 | - |
| 122 | IMCR | Immunocore Holdings plc | 1.47B | -2.53% | 206,663 | 430.78M |
| 123 | PGEN | Precigen, Inc. | 1.45B | -19.88% | 21,257,908 | 156.94M |
| 124 | RAPP | Rapport Therapeutics, Inc. | 1.44B | -6.25% | 375,509 | 20.00M |
| 125 | QURE | uniQure N.V. | 1.43B | -10.29% | 1,881,424 | 20.17M |
| 126 | OCUL | Ocular Therapeutix, Inc. | 1.43B | -8.96% | 2,100,990 | 52.06M |
| 127 | INVA | Innoviva, Inc. | 1.42B | -7.34% | 998,219 | 438.32M |
| 128 | BRVE | Braveheart Bio, Inc. | 1.41B | -14.15% | 1,045,986 | - |
| 129 | MLYS | Mineralys Therapeutics, Inc. | 1.40B | -7.06% | 1,452,661 | - |
| 130 | AAPG | Ascentage Pharma Group International | 1.39B | -1.59% | 3,925 | 94.61M |
| 131 | KRSA | Korsana Biosciences, Inc. | 1.39B | -0.20% | 86,401 | - |
| 132 | ANAB | AnaptysBio, Inc. | 1.38B | -2.55% | 234,281 | 106.09M |
| 133 | GPCR | Structure Therapeutics Inc. | 1.37B | -5.75% | 693,413 | - |
| 134 | TSHA | Taysha Gene Therapies, Inc. | 1.34B | -5.73% | 3,570,687 | 5.49M |
| 135 | DMRA | Damora Therapeutics, Inc. | 1.32B | -6.67% | 450,529 | - |
| 136 | KARD | Kardigan, Inc. | 1.30B | -10.73% | 415,341 | - |
| 137 | GHRS | GH Research PLC | 1.30B | -5.22% | 266,603 | - |
| 138 | URGN | UroGen Pharma Ltd. | 1.26B | -10.16% | 1,640,123 | 250.25M |
| 139 | LBRX | LB Pharmaceuticals Inc | 1.26B | -4.76% | 210,993 | - |
| 140 | OMER | Omeros Corporation | 1.25B | -4.84% | 650,729 | 38.42M |
| 141 | DRTS | Alpha Tau Medical Ltd. | 1.24B | -4.13% | 513,521 | - |
| 142 | NKTR | Nektar Therapeutics | 1.24B | -5.69% | 333,385 | 54.59M |
| 143 | MNKD | MannKind Corporation | 1.21B | -4.07% | 3,692,697 | 393.63M |
| 144 | INBX | Inhibrx Biosciences, Inc. | 1.20B | -5.96% | 143,128 | 1.30M |
| 145 | SLN | Silence Therapeutics plc | 1.19B | -0.13% | 919,565 | 615.00K |
| 146 | AVLN | Avalyn Pharma Inc. | 1.18B | -3.20% | 244,200 | - |
| 147 | VOR | Vor Biopharma Inc. | 1.17B | -5.69% | 373,348 | - |
| 148 | VSTM | Verastem, Inc. | 1.15B | -3.55% | 1,817,058 | 87.53M |
| 149 | SVRA | Savara Inc. | 1.12B | -5.04% | 1,614,685 | - |
| 150 | SGP | SpyGlass Pharma, Inc. | 1.12B | -2.44% | 127,297 | - |
| 151 | SPTX | Seaport Therapeutics, Inc. | 1.08B | -3.63% | 99,307 | - |
| 152 | JANX | Janux Therapeutics, Inc. | 1.03B | -7.70% | 471,996 | 24.00M |
| 153 | JBIO | Jade Biosciences, Inc. | 928.53M | -2.92% | 597,635 | - |
| 154 | MLTX | MoonLake Immunotherapeutics | 921.71M | -6.31% | 854,806 | - |
| 155 | ORIC | ORIC Pharmaceuticals, Inc. | 920.44M | -4.93% | 712,961 | - |
| 156 | ODTX | Odyssey Therapeutics, Inc. | 906.86M | -2.95% | 293,316 | 99.00K |
| 157 | GLUE | Monte Rosa Therapeutics, Inc. | 888.11M | -3.79% | 671,295 | 70.33M |
| 158 | PHAR | Pharming Group N.V. | 883.28M | 0.32% | 12,264 | 386.75M |
| 159 | ANRO | Alto Neuroscience, Inc. | 882.16M | -3.52% | 263,203 | - |
| 160 | RIGL | Rigel Pharmaceuticals, Inc. | 880.20M | -8.13% | 231,116 | 276.79M |
| 161 | LTGO | Latigo Biotherapeutics, Inc. | 871.84M | -6.34% | 355,645 | - |
| 162 | IMTX | Immatics N.V. | 863.88M | -8.54% | 766,062 | 47.65M |
| 163 | CTY | City Therapeutics, Inc. | 848.60M | 3.93% | 100,564 | 14.34M |
| 164 | SNDX | Syndax Pharmaceuticals, Inc. | 847.17M | -9.95% | 3,716,167 | 289.68M |
| 165 | IVA | Inventiva S.A. | 836.63M | -5.81% | 1,988,478 | 2.81M |
| 166 | CRVS | Corvus Pharmaceuticals, Inc. | 831.11M | -6.53% | 680,868 | - |
| 167 | MGTX | MeiraGTx Holdings plc | 827.89M | -8.49% | 353,764 | 397.50M |
| 168 | AKTS | Aktis Oncology, Inc. | 821.50M | -2.83% | 248,143 | 10.06M |
| 169 | PRME | Prime Medicine, Inc. | 796.12M | -9.96% | 3,404,257 | 4.07M |
| 170 | BBTX | Bambusa Therapeutics, Inc. | 783.24M | -4.32% | 321,277 | - |
| 171 | ARDX | Ardelyx, Inc. | 754.12M | -8.81% | 5,082,920 | 468.22M |
| 172 | ANNX | Annexon, Inc. | 749.79M | -8.66% | 2,584,368 | - |
| 173 | ALMS | Alumis Inc. | 748.14M | -11.76% | 1,064,420 | 7.40M |
| 174 | ABUS | Arbutus Biopharma Corporation | 738.96M | -8.00% | 4,891,778 | 181.72M |
| 175 | CGEM | Cullinan Therapeutics, Inc. | 731.07M | -9.05% | 1,181,763 | - |
| 176 | OABI | OmniAb, Inc. | 710.34M | -5.98% | 706,415 | 40.21M |
| 177 | LXRX | Lexicon Pharmaceuticals, Inc. | 707.48M | 7.43% | 3,229,057 | 38.54M |
| 178 | SANA | Sana Biotechnology, Inc. | 700.50M | -8.59% | 1,962,686 | - |
| 179 | ATTO | Attovia Therapeutics, Inc. | 688.88M | -3.27% | 221,762 | 1.80M |
| 180 | DNA | Ginkgo Bioworks Holdings, Inc. | 687.21M | -12.40% | 1,548,670 | 132.42M |
| 181 | SLDB | Solid Biosciences Inc. | 662.65M | -5.21% | 949,741 | - |
| 182 | AURA | Aura Biosciences, Inc. | 661.64M | -4.06% | 396,207 | - |
| 183 | SGMT | Sagimet Biosciences Inc. | 658.74M | -7.01% | 685,236 | - |
| 184 | ACHV | Achieve Life Sciences, Inc. | 655.49M | -8.74% | 1,199,709 | - |
| 185 | ZVRA | Zevra Therapeutics, Inc. | 642.65M | -3.31% | 1,112,628 | 147.76M |
| 186 | HELP | Helus Pharma Inc. | 636.35M | 0.35% | 1,080,284 | - |
| 187 | FDMT | 4D Molecular Therapeutics, Inc. | 635.31M | -6.35% | 803,752 | 92.01M |
| 188 | OBX | Obsidian Therapeutics, Inc. | 635.03M | -6.46% | 342,832 | - |
| 189 | WVE | Wave Life Sciences, Inc. | 629.16M | -11.88% | 3,419,519 | 70.92M |
| 190 | ANL | Adlai Nortye Group Ltd. | 627.56M | 1.40% | 391,113 | 18.06M |
| 191 | CADL | Candel Therapeutics, Inc. | 625.54M | -9.67% | 784,115 | - |
| 192 | KURA | Kura Oncology, Inc. | 625.39M | -7.62% | 2,380,660 | 77.23M |
| 193 | DSGN | Design Therapeutics, Inc. | 617.68M | -7.15% | 314,846 | - |
| 194 | AVBP | ArriVent BioPharma, Inc. | 616.84M | -7.26% | 669,477 | - |
| 195 | GERN | Geron Corporation | 611.57M | -11.86% | 19,685,194 | 217.52M |
| 196 | IMMX | Immix Biopharma, Inc. | 607.68M | -8.03% | 776,277 | - |
| 197 | OLMA | Olema Pharmaceuticals, Inc. | 606.36M | -8.09% | 965,032 | - |
| 198 | APMD | Apnimed, Inc. | 594.07M | -6.73% | 292,753 | 115.12M |
| 199 | DBVT | DBV Technologies S.A. | 591.39M | -3.22% | 234,978 | 3.74M |
| 200 | NVCT | Nuvectis Pharma, Inc. | 578.16M | -3.93% | 245,585 | - |
| 201 | CBIO | Crescent Biopharma, Inc. | 567.54M | -4.05% | 116,624 | 11.88M |
| 202 | ACRS | Aclaris Therapeutics, Inc. | 562.59M | -1.36% | 1,439,181 | 6.40M |
| 203 | BCAX | Bicara Therapeutics Inc. | 557.18M | -5.29% | 481,070 | - |
| 204 | VALN | Valneva SE | 544.61M | 1.07% | 3,473 | 163.30M |
| 205 | NGNE | Neurogene Inc. | 530.00M | -3.97% | 193,514 | 925.00K |
| 206 | PBYI | Puma Biotechnology, Inc. | 521.10M | -5.57% | 242,414 | 231.24M |
| 207 | ENTX | Entera Bio Ltd. | 520.03M | -3.86% | 147,591 | 42.00K |
| 208 | CLYM | Climb Bio, Inc. | 519.22M | -3.11% | 715,284 | - |
| 209 | SLBT | SL Science Holding Limited | 513.24M | -18.92% | 125,907 | 3.27M |
| 210 | SRZN | Surrozen, Inc. | 509.46M | -7.99% | 146,618 | 11.51M |
| 211 | IAM | Iambic Therapeutics, Inc. | 508.14M | -20.00% | 600,607 | 18.25M |
| 212 | FTH | Faeth Therapeutics, Inc. | 508.02M | -1.65% | 167,706 | - |
| 213 | DMAC | DiaMedica Therapeutics Inc. | 496.93M | -14.44% | 224,163 | - |
| 214 | CAPR | Capricor Therapeutics, Inc. | 495.34M | -4.48% | 3,281,094 | 11.13M |
| 215 | OVID | Ovid Therapeutics Inc. | 492.15M | -8.03% | 983,659 | 1.58M |
| 216 | RGNX | REGENXBIO Inc. | 484.54M | -4.80% | 943,572 | 153.91M |
| 217 | YDES | YD Bio Limited | 481.65M | -2.16% | 49,382 | 1.24M |
| 218 | INDP | Indaptus Therapeutics, Inc. | 473.03M | -6.67% | 147,753 | - |
| 219 | CTMX | CytomX Therapeutics, Inc. | 470.66M | -8.09% | 1,973,579 | 18.30M |
| 220 | STTK | Shattuck Labs, Inc. | 463.68M | -10.29% | 922,624 | 1.00M |
| 221 | MNPR | Monopar Therapeutics Inc. | 460.82M | -5.71% | 94,338 | - |
| 222 | ETRA | Electra Therapeutics, Inc. | 453.77M | -9.29% | 291,484 | - |
| 223 | MDXG | MiMedx Group, Inc. | 450.91M | -3.44% | 1,734,380 | 303.73M |
| 224 | EPRX | Eupraxia Pharmaceuticals Inc. | 442.23M | -1.18% | 685,340 | - |
| 225 | GYRE | Gyre Therapeutics, Inc. | 442.16M | -6.08% | 207,882 | 109.82M |
| 226 | OCS | Oculis Holding AG | 435.21M | -3.16% | 235,984 | 1.12M |
| 227 | ARVN | Arvinas, Inc. | 432.86M | -10.92% | 684,623 | 275.30M |
| 228 | PRTA | Prothena Corporation plc | 412.75M | -4.17% | 310,071 | 54.53M |
| 229 | PHAT | Phathom Pharmaceuticals, Inc. | 412.24M | -8.63% | 770,048 | 274.88M |
| 230 | CRMD | CorMedix Inc. | 411.55M | -6.71% | 1,285,732 | 462.25M |
| 231 | ASMB | Assembly Biosciences, Inc. | 406.40M | 0.45% | 202,526 | 74.85M |
| 232 | RLMD | Relmada Therapeutics, Inc. | 401.08M | -9.83% | 1,018,227 | - |
| 233 | BLSM | BlossomHill Therapeutics, Inc. | 400.17M | 1.70% | 261,074 | - |
| 234 | EDIT | Editas Medicine, Inc. | 393.16M | -5.88% | 1,485,450 | 47.01M |
| 235 | RZLT | Rezolute, Inc. | 383.92M | -7.58% | 781,094 | - |
| 236 | TECX | Tectonic Therapeutic, Inc. | 382.97M | -3.50% | 59,815 | - |
| 237 | ALLO | Allogene Therapeutics, Inc. | 381.77M | -7.14% | 12,072,913 | 4.64M |
| 238 | ALT | Altimmune, Inc. | 376.39M | -8.73% | 2,721,085 | 31.00K |
| 239 | PRLD | Prelude Therapeutics Incorporated | 373.87M | -11.03% | 145,157 | 22.42M |
| 240 | LYEL | Lyell Immunopharma, Inc. | 368.92M | -2.43% | 446,907 | 15.00K |
| 241 | CCCC | C4 Therapeutics, Inc. | 364.15M | -5.13% | 2,278,828 | 32.28M |
| 242 | AVTX | Avalo Therapeutics, Inc. | 362.54M | -4.38% | 587,889 | 59.00K |
| 243 | ZURA | Zura Bio Limited | 362.18M | -6.47% | 1,988,486 | - |
| 244 | MPLT | MapLight Therapeutics, Inc. | 352.91M | -5.37% | 232,418 | - |
| 245 | CTNM | Contineum Therapeutics, Inc. | 351.23M | -8.63% | 298,400 | - |
| 246 | TRXB | TRex Bio, Inc. | 349.99M | -4.06% | 129,839 | - |
| 247 | OBIO | Orchestra BioMed Holdings, Inc. | 341.10M | -5.42% | 133,807 | 31.98M |
| 248 | ASPE | Aspen Neuroscience, Inc. | 341.09M | -8.07% | 126,331 | - |
| 249 | AVIR | Atea Pharmaceuticals, Inc. | 340.87M | -4.71% | 163,875 | - |
| 250 | FENC | Fennec Pharmaceuticals Inc. | 338.75M | -6.67% | 87,576 | 59.22M |
| 251 | AUTL | Autolus Therapeutics plc | 335.36M | -8.70% | 2,445,512 | 117.39M |
| 252 | IRD | Opus Genetics, Inc. | 332.78M | -6.32% | 1,103,052 | 9.86M |
| 253 | AGMB | AgomAb Therapeutics NV | 332.18M | -1.53% | 49,126 | - |
| 254 | VCRE | Vicore Pharma Holding AB (publ) | 325.08M | 12.39% | 27,089 | 383.48K |
| 255 | EIKN | Eikon Therapeutics, Inc. | 324.72M | -6.18% | 494,028 | - |
| 256 | PROK | ProKidney Corp. | 320.46M | -5.36% | 1,014,043 | 818.00K |
| 257 | BNTC | Benitec Biopharma Inc. | 305.92M | -5.50% | 214,817 | - |
| 258 | ALEC | Alector, Inc. | 303.93M | -10.09% | 898,792 | 13.86M |
| 259 | XFOR | X4 Pharmaceuticals, Inc. | 303.39M | -5.56% | 462,298 | 16.96M |
| 260 | ENTA | Enanta Pharmaceuticals, Inc. | 300.57M | -3.10% | 188,935 | 65.26M |
| 261 | SCTX | Scribe Therapeutics Inc. | 299.12M | -5.84% | 233,230 | 33.30M |
| 262 | GALT | Galectin Therapeutics Inc. | 298.51M | -14.70% | 297,542 | - |
| 263 | KYTX | Kyverna Therapeutics, Inc. | 287.88M | -9.79% | 1,150,692 | - |
| 264 | DTIL | Precision BioSciences, Inc. | 287.46M | 26.72% | 2,370,535 | 45.04M |
| 265 | AGEN | Agenus Inc. | 286.78M | -8.61% | 1,001,368 | 132.69M |
| 266 | CUVL | Clinuvel Pharmaceuticals Limited | 282.17M | 3.88% | 3,082 | 65.05M |
| 267 | FULC | Fulcrum Therapeutics, Inc. | 281.54M | -2.12% | 1,204,779 | 80.00M |
| 268 | VTVT | vTv Therapeutics Inc. | 278.06M | -6.87% | 14,172 | 36.84M |
| 269 | IPSC | Century Therapeutics, Inc. | 277.05M | -8.38% | 407,604 | 109.16M |
| 270 | OCGN | Ocugen, Inc. | 273.93M | -7.63% | 5,341,121 | 4.78M |
| 271 | SPRY | ARS Pharmaceuticals, Inc. | 273.48M | -9.84% | 1,806,652 | 116.93M |
| 272 | SABS | SAB Biotherapeutics, Inc. | 269.32M | -6.92% | 208,364 | 114.70K |
| 273 | ARCT | Arcturus Therapeutics Holdings Inc. | 268.88M | -12.97% | 527,372 | 29.37M |
| 274 | VOGX | Vogenx, Inc. | 267.54M | -8.72% | 62,848 | - |
| 275 | RCKT | Rocket Pharmaceuticals, Inc. | 264.01M | -7.85% | 1,579,669 | - |
| 276 | IKT | Inhibikase Therapeutics, Inc. | 263.10M | -7.67% | 498,885 | 1.00 |
| 277 | NAUT | Nautilus Biotechnology, Inc. | 261.75M | -10.26% | 5,749,573 | 424.00K |
| 278 | QTTB | Q32 Bio Inc. | 261.08M | -2.23% | 447,185 | 53.74M |
| 279 | TTRX | Turn Therapeutics Inc. | 255.58M | -12.45% | 111,307 | - |
| 280 | LCTX | Lineage Cell Therapeutics, Inc. | 250.05M | -4.01% | 2,033,342 | 13.08M |
| 281 | BCYC | Bicycle Therapeutics plc | 246.73M | -5.38% | 368,957 | 83.53M |
| 282 | LRMR | Larimar Therapeutics, Inc. | 245.82M | -14.67% | 1,338,854 | - |
| 283 | EVMN | Evommune, Inc. | 234.99M | 7.20% | 839,813 | 10.00M |
| 284 | LXEO | Lexeo Therapeutics, Inc. | 234.23M | -11.61% | 1,046,622 | - |
| 285 | CAMP | Camp4 Therapeutics Corporation | 230.93M | -1.60% | 92,796 | 4.22M |
| 286 | ABEO | Abeona Therapeutics Inc. | 225.59M | -6.52% | 940,679 | 25.52M |
| 287 | FATE | Fate Therapeutics, Inc. | 222.87M | -11.00% | 2,326,904 | 6.49M |
| 288 | IMRX | Immuneering Corporation | 219.55M | -9.84% | 507,497 | - |
| 289 | KRRO | Korro Bio, Inc. | 219.26M | -10.41% | 335,921 | 1.29M |
| 290 | VNDA | Vanda Pharmaceuticals Inc. | 218.30M | -6.96% | 721,136 | 229.28M |
| 291 | CABA | Cabaletta Bio, Inc. | 216.17M | -10.21% | 4,849,784 | - |
| 292 | GLSI | Greenwich LifeSciences, Inc. | 215.62M | -10.15% | 206,077 | - |
| 293 | ACIU | AC Immune SA | 211.28M | -7.21% | 227,379 | 23.75M |
| 294 | SLGL | Sol-Gel Technologies Ltd. | 208.29M | -3.61% | 6,747 | 1.80M |
| 295 | RNAC | Cartesian Therapeutics, Inc. | 206.64M | 0.15% | 111,823 | 1.03M |
| 296 | IFRX | InflaRx N.V. | 203.37M | -6.76% | 1,310,535 | -38.53K |
| 297 | PLX | Protalix BioTherapeutics, Inc. | 203.04M | -6.32% | 775,192 | 80.62M |
| 298 | ARTV | Artiva Biotherapeutics, Inc. | 202.41M | -1.90% | 684,160 | 251.00K |
| 299 | DRUG | Bright Minds Biosciences Inc. | 198.88M | 7.81% | 347,772 | - |
| 300 | ELDN | Eledon Pharmaceuticals, Inc. | 197.66M | -10.00% | 502,368 | - |
| 301 | PALI | Palisade Bio, Inc. | 195.18M | -10.40% | 2,122,713 | 500.00K |
| 302 | PYXS | Pyxis Oncology, Inc. | 192.32M | -3.01% | 872,166 | 11.04M |
| 303 | KROS | Keros Therapeutics, Inc. | 191.93M | -10.62% | 138,155 | 15.01M |
| 304 | PRQR | ProQR Therapeutics N.V. | 191.22M | -3.90% | 865,914 | 21.05M |
| 305 | CGEN | Compugen Ltd. | 185.66M | -3.45% | 240,680 | 74.00M |
| 306 | ACOG | Alpha Cognition Inc. | 177.93M | -4.22% | 33,859 | 15.26M |
| 307 | WHWK | Whitehawk Therapeutics, Inc. | 177.30M | -1.89% | 515,037 | 7.15M |
| 308 | MDWD | MediWound Ltd. | 176.74M | -3.59% | 191,280 | 11.86M |
| 309 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 174.78M | -5.22% | 444,399 | - |
| 310 | IVVD | Invivyd, Inc. | 173.44M | -7.13% | 3,832,872 | 58.37M |
| 311 | UPB | Upstream Bio, Inc. | 171.43M | -15.41% | 617,140 | 3.16M |
| 312 | TRDA | Entrada Therapeutics, Inc. | 166.94M | -8.50% | 147,768 | 3.98M |
| 313 | ORMP | Oramed Pharmaceuticals Inc. | 164.73M | -4.12% | 140,701 | 2.00M |
| 314 | PEPG | PepGen Inc. | 161.03M | -5.10% | 762,404 | - |
| 315 | ZNTL | Zentalis Pharmaceuticals, Inc. | 160.94M | -3.41% | 1,284,101 | 26.87M |
| 316 | ALXO | ALX Oncology Holdings Inc. | 159.71M | -15.07% | 414,751 | - |
| 317 | CNTN | Canton Strategic Holdings, Inc. | 155.38M | -9.72% | 429,266 | 1.50M |
| 318 | STRO | Sutro Biopharma, Inc. | 153.79M | -6.69% | 501,201 | 45.70M |
| 319 | SION | Sionna Therapeutics, Inc. | 153.08M | -9.23% | 530,040 | - |
| 320 | ANTX | AN2 Therapeutics, Inc. | 151.13M | -5.76% | 99,101 | - |
| 321 | INO | Inovio Pharmaceuticals, Inc. | 150.96M | -9.88% | 11,561,288 | 65.34K |
| 322 | MGNX | MacroGenics, Inc. | 144.92M | -1.52% | 794,280 | 175.14M |
| 323 | RNA | Atrium Therapeutics, Inc. | 144.03M | -3.00% | 120,954 | 35.84M |
| 324 | NGEN | NervGen Pharma Corp. | 143.01M | -1.48% | 258,092 | - |
| 325 | ADAG | Adagene Inc. | 139.66M | -13.69% | 319,781 | 9.29M |
| 326 | VRXA | Veraxa Biotech AG | 136.22M | 1.40% | 136,609 | 29.54K |
| 327 | MSLE | Satellos Bioscience Inc. | 135.47M | -4.25% | 72,389 | - |
| 328 | TARA | Protara Therapeutics, Inc. | 130.60M | -5.96% | 419,292 | - |
| 329 | IPHA | Innate Pharma S.A. | 129.12M | -2.08% | 10,860 | 11.21M |
| 330 | CMPX | Compass Therapeutics, Inc. | 126.42M | -7.96% | 1,806,540 | 850.00K |
| 331 | CUE | Cue Biopharma, Inc. | 125.89M | -12.65% | 84,563 | 37.66M |
| 332 | SPRB | Spruce Biosciences, Inc. | 124.70M | -6.91% | 42,265 | 697.00K |
| 333 | YARW | Yarrow Bioscience, Inc. | 124.49M | -10.26% | 199,017 | - |
| 334 | MENS | Jyong Biotech Ltd. | 123.23M | -4.60% | 25,473 | - |
| 335 | MOLN | Molecular Partners AG | 118.61M | -2.68% | 4,743 | 856.30K |
| 336 | CHRS | Coherus Oncology, Inc. | 116.90M | -11.01% | 1,557,086 | 50.94M |
| 337 | PYPD | PolyPid Ltd. | 115.68M | -2.15% | 231,213 | - |
| 338 | NKTX | Nkarta, Inc. | 114.96M | -7.23% | 813,435 | - |
| 339 | ENGN | enGene Therapeutics Inc. | 112.92M | -2.03% | 450,958 | - |
| 340 | NERV | Minerva Neurosciences, Inc. | 111.73M | -8.95% | 129,742 | - |
| 341 | CDXS | Codexis, Inc. | 111.70M | -5.56% | 677,182 | 77.68M |
| 342 | ARMP | Armata Pharmaceuticals, Inc. | 111.55M | -4.46% | 30,446 | 5.54M |
| 343 | HUMA | Humacyte, Inc. | 110.70M | -11.44% | 4,967,469 | 2.12M |
| 344 | FHTX | Foghorn Therapeutics Inc. | 109.57M | -12.14% | 571,656 | 36.74M |
| 345 | NBP | NovaBridge Biosciences | 107.61M | -8.15% | 752,921 | - |
| 346 | ANIX | Anixa Biosciences, Inc. | 106.66M | -6.46% | 143,350 | - |
| 347 | OTLK | Outlook Therapeutics, Inc. | 106.07M | -5.71% | 3,655,633 | -1.16M |
| 348 | VYGR | Voyager Therapeutics, Inc. | 105.98M | -8.02% | 886,915 | 34.46M |
| 349 | OKUR | OnKure Therapeutics, Inc. | 104.08M | -0.77% | 298,589 | - |
| 350 | EQ | Equillium, Inc. | 103.44M | -5.71% | 225,104 | 4.39M |
| 351 | HURA | TuHURA Biosciences, Inc. | 103.24M | -5.81% | 469,077 | - |
| 352 | IMUX | Immunic, Inc. | 102.61M | -5.29% | 190,561 | - |
| 353 | AVXL | Anavex Life Sciences Corp. | 102.43M | -12.30% | 1,072,875 | - |
| 354 | NRXP | NRx Pharmaceuticals, Inc. | 100.37M | -6.83% | 708,086 | 3.39M |
| 355 | KZIA | Kazia Therapeutics Limited | 99.35M | -10.27% | 157,031 | 1.27M |
| 356 | MIST | Milestone Pharmaceuticals Inc. | 97.67M | -10.28% | 931,887 | 2.34M |
| 357 | BDTX | Black Diamond Therapeutics, Inc. | 97.10M | -11.05% | 433,338 | 70.00M |
| 358 | UNCY | Unicycive Therapeutics, Inc. | 96.94M | -7.20% | 1,156,037 | - |
| 359 | LENZ | LENZ Therapeutics, Inc. | 96.46M | -11.27% | 508,042 | 12.36M |
| 360 | PMVP | PMV Pharmaceuticals, Inc. | 95.90M | -4.15% | 425,326 | - |
| 361 | NMRA | Neumora Therapeutics, Inc. | 94.77M | -10.88% | 1,194,305 | - |
| 362 | TENX | Tenax Therapeutics, Inc. | 93.37M | -9.94% | 1,475,242 | - |
| 363 | VANI | Vivani Medical, Inc. | 92.46M | -4.21% | 339,334 | - |
| 364 | SEER | Seer, Inc. | 91.64M | -2.65% | 73,639 | 14.22M |
| 365 | RTSN | Retension Pharmaceuticals, Inc. | 90.65M | -6.17% | 103,203 | - |
| 366 | ICCC | ImmuCell Corporation | 90.28M | -4.15% | 6,030 | 30.68M |
| 367 | PLYX | Polaryx Therapeutics, Inc. | 89.72M | - | 58,626 | - |
| 368 | CBUS | Cibus, Inc. | 87.89M | -7.26% | 67,788 | 4.35M |
| 369 | PDSB | PDS Biotechnology Corporation | 85.16M | -9.62% | 2,866,318 | - |
| 370 | RLYB | Rallybio Corporation | 84.80M | -0.94% | 17,046 | 434.00K |
| 371 | GNLX | Genelux Corporation | 84.69M | -3.57% | 199,927 | 8.00K |
| 372 | TVGN | Tevogen Inc. | 81.99M | -8.92% | 3,227 | - |
| 373 | TLSA | Tiziana Life Sciences Ltd | 79.76M | -2.35% | 677,847 | - |
| 374 | TNXP | Tonix Pharmaceuticals Holding Corp. | 79.24M | -9.59% | 1,019,138 | 29.10M |
| 375 | ATRA | Atara Biotherapeutics, Inc. | 79.00M | -5.97% | 19,058 | 6.19M |
| 376 | NTHI | NeOnc Technologies Holdings, Inc. | 76.06M | -3.47% | 113,131 | 39.99K |
| 377 | NRXS | NeurAxis, Inc. | 75.47M | -12.39% | 169,254 | 5.32M |
| 378 | CLLS | Cellectis S.A. | 75.27M | -11.97% | 64,925 | 63.82M |
| 379 | OKYO | OKYO Pharma Limited | 72.95M | -2.80% | 41,807 | - |
| 380 | RANI | Rani Therapeutics Holdings, Inc. | 72.28M | -9.48% | 539,339 | 4.88M |
| 381 | MNOV | MediciNova, Inc. | 71.37M | - | 110,333 | 920.48K |
| 382 | TNYA | Tenaya Therapeutics, Inc. | 69.80M | -15.84% | 5,780,671 | 1.34M |
| 383 | ACRV | Acrivon Therapeutics, Inc. | 67.71M | -9.20% | 268,412 | - |
| 384 | CNXU | Conexeu Sciences Inc. | 66.90M | -2.25% | 145,938 | - |
| 385 | COYA | Coya Therapeutics, Inc. | 66.85M | -7.47% | 268,171 | 8.02M |
| 386 | CSBR | Champions Oncology, Inc. | 66.25M | -1.45% | 9,108 | 60.66M |
| 387 | NTRB | Nutriband Inc. | 65.28M | -11.68% | 32,752 | 1.62M |
| 388 | CING | Cingulate Inc. | 62.97M | -5.04% | 125,721 | - |
| 389 | MAIA | MAIA Biotechnology, Inc. | 62.95M | -9.21% | 294,486 | - |
| 390 | FBIO | Fortress Biotech, Inc. | 62.37M | -5.08% | 241,047 | 68.47M |
| 391 | CGTX | Cognition Therapeutics, Inc. | 61.12M | -5.94% | 636,458 | - |
| 392 | CRDF | Cardiff Oncology, Inc. | 59.52M | -11.95% | 634,911 | 508.00K |
| 393 | SPRO | Spero Therapeutics, Inc. | 58.82M | -5.61% | 676,870 | 47.00M |
| 394 | TELO | Telomir Pharmaceuticals, Inc. | 58.53M | -9.14% | 153,677 | - |
| 395 | XBIT | XBiotech Inc. | 57.62M | -3.08% | 24,413 | - |
| 396 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 57.54M | -16.67% | 914,677 | - |
| 397 | GOSS | Gossamer Bio, Inc. | 57.04M | -6.28% | 127,497 | 53.29M |
| 398 | ONCY | Oncolytics Biotech Inc. | 56.04M | 3.46% | 2,593,082 | - |
| 399 | BOLD | Boundless Bio, Inc. | 54.82M | 0.42% | 62,344 | - |
| 400 | RNXT | RenovoRx, Inc. | 54.16M | -8.40% | 294,643 | 1.98M |
| 401 | CLNN | Clene Inc. | 54.01M | -7.32% | 79,793 | 238.00K |
| 402 | VRCA | Verrica Pharmaceuticals Inc. | 53.60M | -9.70% | 108,985 | 30.32M |
| 403 | ALPS | Alps Group Inc | 53.21M | -0.06% | 35,984 | 3.74M |
| 404 | HRTX | Heron Therapeutics, Inc. | 52.85M | -6.76% | 1,112,236 | 151.18M |
| 405 | KLRS | Kalaris Therapeutics, Inc. | 52.85M | 9.90% | 88,705 | - |
| 406 | RNTX | Rein Therapeutics Inc. | 51.77M | -8.90% | 235,098 | - |
| 407 | INKT | MiNK Therapeutics, Inc. | 51.29M | -5.19% | 15,432 | - |
| 408 | XLO | Xilio Therapeutics, Inc. | 51.26M | -10.56% | 10,092 | 64.09M |
| 409 | ELOX | Eloxx Pharmaceuticals, Inc. | 50.94M | -0.94% | 20,443 | - |
| 410 | PLRX | Pliant Therapeutics, Inc. | 50.22M | -4.79% | 225,418 | - |
| 411 | HOWL | Werewolf Therapeutics, Inc. | 49.63M | -6.30% | 250,099 | 21.00M |
| 412 | TIL | Instil Bio, Inc. | 47.95M | 1.14% | 82,177 | - |
| 413 | IBIO | iBio, Inc. | 46.92M | -8.80% | 624,381 | 100.00K |
| 414 | HYFT | MindWalk Holdings Corp. | 46.87M | -4.34% | 451,947 | 11.57M |
| 415 | IMA | ImageneBio, Inc. | 46.77M | 0.49% | 11,191 | 800.00K |
| 416 | MREO | Mereo BioPharma Group plc | 45.33M | -6.35% | 842,052 | 500.00K |
| 417 | CRBU | Caribou Biosciences, Inc. | 44.80M | -5.96% | 1,472,439 | 10.04M |
| 418 | CNTB | Connect Biopharma Holdings Limited | 44.72M | -9.02% | 319,411 | 2.95M |
| 419 | ATHE | Alterity Therapeutics Limited | 43.48M | -4.92% | 36,457 | 2.50M |
| 420 | OSTX | OS Therapies Incorporated | 42.80M | -19.44% | 3,198,993 | - |
| 421 | GANX | Gain Therapeutics, Inc. | 42.33M | -12.61% | 755,114 | - |
| 422 | BMEA | Biomea Fusion, Inc. | 41.63M | -6.13% | 1,232,806 | - |
| 423 | ATNM | Actinium Pharmaceuticals, Inc. | 41.56M | -6.25% | 166,558 | 35.09M |
| 424 | LONA | LeonaBio, Inc. | 41.27M | -4.05% | 91,289 | - |
| 425 | SER | Serina Therapeutics, Inc. | 41.00M | -4.49% | 18,368 | 130.00K |
| 426 | HYPD | Hyperion DeFi, Inc. | 40.56M | -14.98% | 283,587 | 1.40M |
| 427 | EXOZ | eXoZymes, Inc. | 38.15M | -4.64% | 6,982 | -700.00 |
| 428 | GRCE | Grace Therapeutics, Inc. | 37.65M | -1.10% | 82,295 | - |
| 429 | APLM | Apollomics, Inc. | 37.27M | -10.68% | 12,024 | 8.84M |
| 430 | PTHS | Pelthos Therapeutics Inc. | 36.99M | -4.80% | 21,488 | 43.30M |
| 431 | ELTX | Elicio Therapeutics, Inc. | 36.79M | -10.26% | 228,617 | - |
| 432 | INMB | INmune Bio Inc. | 36.75M | -10.15% | 415,664 | 50.00K |
| 433 | VERU | Veru Inc. | 36.06M | -3.86% | 173,935 | 16.89M |
| 434 | ALDX | Aldeyra Therapeutics, Inc. | 35.51M | -9.07% | 688,832 | - |
| 435 | GRDX | GridAI Technologies Corp. | 35.12M | -8.66% | 126,444 | - |
| 436 | IBO | Impact BioMedical Inc. | 34.69M | -0.98% | 7,697 | 35.00K |
| 437 | DWTX | Dogwood Therapeutics, Inc. | 33.99M | -2.92% | 155,046 | - |
| 438 | NNVC | NanoViricides, Inc. | 33.44M | -5.08% | 143,389 | - |
| 439 | PMN | ProMIS Neurosciences, Inc. | 32.46M | 2.84% | 233,001 | - |
| 440 | ACET | Adicet Bio, Inc. | 32.19M | -3.55% | 382,655 | - |
| 441 | EYPT | EyePoint, Inc. | 30.92M | -9.22% | 2,939,679 | 2.79M |
| 442 | LITS | Lite Strategy, Inc. | 30.71M | -6.48% | 467,224 | - |
| 443 | ALGS | Aligos Therapeutics, Inc. | 29.16M | -6.97% | 35,735 | 31.52M |
| 444 | IRLA | IRulya Therapeutics Inc. | 29.08M | -9.71% | 44,356 | - |
| 445 | EDSA | Edesa Biotech, Inc. | 28.91M | -1.38% | 29,229 | - |
| 446 | BCTX | BriaCell Therapeutics Corp. | 28.79M | 3.45% | 72,513 | - |
| 447 | PLRZ | Polyrizon Ltd. | 28.45M | 5.30% | 14,889 | - |
| 448 | MGX | Metagenomi Therapeutics, Inc. | 27.18M | -8.92% | 89,416 | 13.56M |
| 449 | BYSI | BeyondSpring Inc. | 26.73M | -4.27% | 87,226 | 1.88M |
| 450 | ANVS | Annovis Bio, Inc. | 26.73M | -48.16% | 27,960,472 | - |
| 451 | RNAZ | TransCode Therapeutics, Inc. | 25.57M | -5.63% | 17,972 | - |
| 452 | NXTC | NextCure, Inc. | 25.40M | -5.13% | 11,718 | - |
| 453 | ABVC | ABVC BioPharma, Inc. | 25.19M | -2.99% | 5,327 | 797.92K |
| 454 | AARD | Aardvark Therapeutics, Inc. | 24.07M | -12.70% | 303,931 | - |
| 455 | CELU | Celularity Inc. | 23.82M | -9.26% | 156,722 | 18.67M |
| 456 | CVM | CEL-SCI Corporation | 23.22M | -4.35% | 80,426 | - |
| 457 | EVAX | Evaxion A/S | 23.15M | -6.53% | 96,614 | 7.49M |
| 458 | FLNA | Filana Therapeutics, Inc. | 23.02M | -16.70% | 933,385 | - |
| 459 | CRVO | CervoMed Inc. | 22.68M | -3.85% | 266,190 | 331.30K |
| 460 | MCRB | Seres Therapeutics, Inc. | 20.49M | -2.39% | 86,800 | 2.13M |
| 461 | IMMP | Immutep Limited | 20.37M | -5.42% | 13,580 | 13.79M |
| 462 | ATOS | Atossa Therapeutics, Inc. | 20.26M | -4.25% | 49,798 | - |
| 463 | COCP | Cocrystal Pharma, Inc. | 19.26M | -0.99% | 47,843 | 330.00K |
| 464 | BSEM | BioStem Technologies, Inc. | 19.11M | -10.57% | 147,491 | 34.59M |
| 465 | IGC | IGC Pharma, Inc. | 18.68M | -7.33% | 753,126 | 1.11M |
| 466 | ACTU | Actuate Therapeutics, Inc. | 18.57M | -8.71% | 427,874 | - |
| 467 | AKTX | Akari Therapeutics, Plc | 18.03M | -15.07% | 26,675 | - |
| 468 | QNRX | Quoin Pharmaceuticals, Ltd. | 18.02M | -6.72% | 10,174 | - |
| 469 | QNTM | Quantum BioPharma Ltd. | 17.95M | -4.07% | 72,439 | - |
| 470 | CNTX | Context Therapeutics Inc. | 17.43M | -6.78% | 1,050,423 | - |
| 471 | ESLA | Estrella Immunopharma, Inc. | 17.40M | -9.81% | 139,756 | - |
| 472 | BOLT | Bolt Biotherapeutics, Inc. | 16.78M | -0.76% | 123,470 | 4.70M |
| 473 | KTTA | Pasithea Therapeutics Corp. | 16.49M | -6.87% | 603,849 | - |
| 474 | NCEL | NewcelX Ltd. | 15.83M | 7.03% | 32,413 | - |
| 475 | JSPR | Jasper Therapeutics, Inc. | 15.72M | -7.55% | 421,930 | - |
| 476 | ALLR | Allarity Therapeutics, Inc. | 15.71M | -8.60% | 153,756 | 345.00K |
| 477 | ABOS | Acumen Pharmaceuticals, Inc. | 15.36M | -1.85% | 5,673,489 | - |
| 478 | KYNB | Kyntra Bio, Inc. | 15.18M | -5.30% | 28,004 | 4.62M |
| 479 | CTXR | Citius Pharmaceuticals, Inc. | 15.11M | -0.13% | 327,883 | 7.11M |
| 480 | NEUP | Neuphoria Therapeutics Inc. | 14.80M | -8.22% | 37,382 | 1.17M |
| 481 | ATYR | aTyr Pharma, Inc. | 14.79M | -2.43% | 46,050 | 190.00K |
| 482 | MRKR | Marker Therapeutics, Inc. | 14.67M | -12.87% | 174,944 | 3.55M |
| 483 | PLUR | Pluri Inc. | 14.26M | -6.10% | 25,748 | 1.02M |
| 484 | BCDA | BioCardia, Inc. | 13.17M | -4.72% | 115,641 | 3.00K |
| 485 | LPCN | Lipocine Inc. | 12.78M | 7.64% | 380,247 | 1.57M |
| 486 | DYAI | Dyadic International, Inc. | 12.75M | -4.55% | 70,593 | 3.80M |
| 487 | DARE | Daré Bioscience, Inc. | 12.36M | -5.09% | 143,208 | 1.37M |
| 488 | TCRX | TScan Therapeutics, Inc. | 12.26M | -13.86% | 556,064 | 7.11M |
| 489 | GUTS | Fractyl Health, Inc. | 11.87M | -7.97% | 131,742 | 3.00K |
| 490 | TVRD | Tvardi Therapeutics, Inc. | 11.36M | -1.17% | 157,273 | - |
| 491 | HIND | Vyome Holdings, Inc. | 11.30M | -7.25% | 45,566 | 129.73K |
| 492 | PBM | Psyence Biomedical Ltd. | 11.10M | -8.48% | 28,433 | - |
| 493 | PASG | Passage Bio, Inc. | 10.96M | -2.99% | 20,544 | - |
| 494 | CLRB | Cellectar Biosciences, Inc. | 10.87M | -6.50% | 134,930 | - |
| 495 | PPBT | Purple Biotech Ltd | 10.70M | 2.06% | 73,523 | - |
| 496 | KPRX | Kiora Pharmaceuticals, Inc. | 10.05M | -4.82% | 25,567 | 20.00K |
| 497 | ICU | SeaStar Medical Holding Corporation | 10.05M | -6.37% | 52,977 | 1.71M |
| 498 | GDTC | CytoMed Therapeutics Limited | 9.91M | -6.63% | 938 | 609.73K |
| 499 | INTS | Intensity Therapeutics, Inc. | 9.30M | -18.57% | 35,423 | - |
| 500 | PHIO | Phio Pharmaceuticals Corp. | 9.29M | -8.04% | 103,119 | - |